TRENDS OF MODULAR MOBILE CLEANROOM FACILITIES SMALL FOOTPRINT. MAJOR PRODUCTION. Faster. Flexible. Mobile. Changes in the Industry Increasing process intensification from increasing expression rates or new processing technology reduces facility footprint Regulators support agile, efficient and flexible manufacturing plat- forms New manufacturing sites need to be multi-product/purpose sites to increase utilization Regenerative/personalized medi- cines require robust containment and the ability to manufacture in multiple production sites Benefits of Prefabricated Systems Aligns with emerging product classes and smaller patient popu- lations Reduces cost Allows for regional manufacturing Enhances speed to clinic and market Repurposable for multi-product lifecycles or processes Contact Us: www.gconbio.com P: 979.431.0700 | E: [email protected] Process Intensification = Smaller Facility Footprints Changes in the Process De-risking Faster Turnaround Closed Systems Capacity Flexing Process Step Reduction Changes in Infrastructure Small Footprint Fast Deployment Flexibility and Scalability Autonomous Containment Repurposability Prefabricated cleanrooms enable production of biopharmaceuticals and cell and gene therapies at lower capital cost than traditional fixed facilities. Prefabricated cleanrooms can provide a standardized manufacturing platform that is readily deployable across the globe allowing customers to save time and cost. Reducing the size of processes and facilities allow the prefabricated approach to provide effective delivery of all therapies, including low volume therapies, through multiple regional production sites.

Trends of Modular Mobile Cleanroom Facilities

Download PDF Report

Upload
brittany-berryman
View
59
Download
3

Embed Size (px)

Citation preview

TRENDS OF MODULAR MOBILE CLEANROOM FACILITIES

SMALL FOOTPRINT. MAJOR PRODUCTION.Faster. Flexible. Mobile.

Changes in the Industry Increasing process intensification from increasing expression rates or new processing technology reduces facility footprint Regulators support agile, efficient and flexible manufacturing plat- forms New manufacturing sites need to be multi-product/purpose sites to increase utilization Regenerative/personalized medi- cines require robust containment and the ability to manufacture in multiple production sites

Benefits of Prefabricated Systems Aligns with emerging product classes and smaller patient popu- lations Reduces cost Allows for regional manufacturing Enhances speed to clinic and market Repurposable for multi-product lifecycles or processes

P: 979.431.0700 | E: [email protected]

Process Intensification = Smaller Facility Footprints

Changes in the Process

De-risking

Faster Turnaround

Closed Systems

Capacity Flexing

Process Step Reduction

Changes in Infrastructure

Small Footprint

Fast Deployment

Flexibility and Scalability

Autonomous Containment

Repurposability

Prefabricated cleanrooms enable production of biopharmaceuticalsand cell and gene therapies at lower capital cost than traditional fixed facilities. Prefabricated cleanrooms can provide a standardized manufacturing platform that is readily deployable across the globe allowing customers to save time and cost. Reducing the size of processes and facilities allow the prefabricated approach to provide effective delivery of all therapies, including low volume therapies, through multiple regional production sites.